Todd Foley, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 230,670 shares at $25.41 ($5.8M) on 2020-06-25, disclosed to the SEC on 2020-06-25.
Open-market sale of $5.8M RYTM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.34 | 97,388 | $2.5M | 42.2% |
| 2 | $25.34 | 97,388 | $2.5M | 42.2% |
| 3 | $25.41 | 17,947 | $456K | 7.8% |
| 4 | $25.41 | 17,947 | $456K | 7.8% |
| Total | $25.35 avg | 230,670 | $5.8M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |